Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why Command Centers Have Proven Savvy Investments for Hospitals

2020 has been the year of the dashboard, of ICU counts and of bed counts. For many around the world, hospital statistics went from an afterthought to a daily part of life, as they logged on to see how their local emergency rooms were coping with the coronavirus pandemic in their communities. Hospitals that had…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

2020 has been the year of the dashboard, of ICU counts and of bed counts. For many around the world, hospital statistics went from an afterthought to a daily part of life, as they logged on to see how their local emergency rooms were coping with the coronavirus pandemic in their communities.

Hospitals that had built-in command centers had a leg up, said Gip Sisson, Senior Project Manager for Constant Technologies. With data already at administrators’ fingertips, they were able to plot the best course of action and quickly react as things changed.

“The front of these work groups allows the staff to see the entire overview of the hospital in real time. The central location allows for better communication, faster decision-making and, using predictive-type software and the information getting fed into the hospital system, they can see the hospital data and project it out one day, one week or one month in advance,” he said.

“This is something that improves the hospital efficiency. The key is to spot the potential bottlenecks before the happen. Providing them the tools to do that is something that Constant has taken some pride in and enjoyed working on.”

With command centers proving a savvy investment for so many hospitals as they cope with the pandemic, Sisson said more around the world might follow suit.

“I think any time you can prove that the efficiency gained through a command center results in a bottom line, a hospital is going to take a strong look at that. So, in that sense, I think these command centers are going to continue to catch on,” Sisson said.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512